The results from subgroup analysis by ACPA seropositivity revealed the association of BMI or obesity with RA risk in ACPA-positive RA rather than ACPA-negative RA, suggesting that BMI plays a different role in these two major RA subsets based on the presence of ACPA. The gene discussed is PRTN3; the disease is obesity due to melanocortin 4 receptor deficiency.